⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTR News
Nektar Therapeutics
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
NKTR
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
globenewswire.com
ADAR
NKTR
Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035
globenewswire.com
MRK
AZN
CRSP
BGNE
NKTR
ALKS
XNNY
BMY
New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
prnewswire.com
NKTR
Nektar Therapeutics Reports Third Quarter 2025 Financial Results
prnewswire.com
NKTR
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
prnewswire.com
NKTR
Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets
prnewswire.com
NKTR
Nektar Presents New Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin in Late-Breaker Oral Presentation at EADV 2025
prnewswire.com
NKTR
Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025
prnewswire.com
NKTR